Windtree Therapeutics, a Nasdaq listed biotechnology company, has plans to raise up to $200 million to build a treasury of ...

Biotech stories typically tread a very fine line between promise and pressure. Sometimes a company that’s been a pioneer in ...

Inhibrx Biosciences rises on early clinical success; Ozekibart shows promise in colorectal cancer. Read here for an analysis ...

Ben Lamm, CEO of Colossal Biosciences, wanted to ensure his brand was approachable to all, fun, educational and full of ...

Niagen Bioscience CEO Robert Fried discusses the science of NAD, the problems with the supplement industry, and how his company is leading the way in anti-aging research.

We recently published 10 Stocks Exploded Over 100%; One Shockingly Soared 11,000%. Regencell Bioscience Holdings Limited ...

Caribou Biosciences' allogeneic CAR T-cell therapies show promising early efficacy and safety, but require clinical ...

Harvard Bioscience has yet another leadership shakeup as the Holliston-based biotech firm’s CEO is set to retire and two new ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

A species of huge, flightless bird that once inhabited New Zealand disappeared around 600 years ago, shortly after human ...

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin ...

Colossal Biosciences, a genetic engineering startup based in Dallas, wants to revive the moa, a flightless bird species that ...